This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Olaparib with or without cediranib in treating pat...
Clinical trial

Olaparib with or without cediranib in treating patients with metastatic hormone-resistant prostate cancer

Read time: 3 mins
Last updated:1st Dec 2016
Identifier: NCT02893917
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest